findmyKOL

Michael Humeniuk, MD

Basic profile

Spartanburg Regional Medical Center

ORCIDNone on fileNPI↗
RegionSpartanburg, SC · SoutheastSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding2026–2026Why? →

Michael Humeniuk is an Oncology physician affiliated with Spartanburg Regional Medical Center. OpenAlex indexes 30 publications with 503 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
30publications

Distinct works indexed by OpenAlex.

503citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 2026–2026

Federally funded research awards.

View funding ↓

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    29.9%
    Corticosteroid21.1%
    Prednisone100%
    Part D≥101 patients
    Serotonin-3 Receptor Antagonist2.9%
    Ondansetron Hcl82%Ondansetron Odt18%
    Part D<11 patients

    + 5 more classes in this area

  • Cancer & immunology

    26.8%
    Cytochrome P450 17A1 Inhibitor21.3%
    Abiraterone Acetate100%
    Part D≥61 patients
    Androgen Receptor Inhibitor3.9%
    Xtandi61%Bicalutamide40%
    Part D<11 patients

    + 1 more class in this area

  • Nervous system

    22.3%
    Opioid Agonist8.1%
    Morphine Sulfate Er22%Morphine Sulfate21%Tramadol Hcl18%Oxycodone Hcl17%Oxycodone-Acetaminophen15%Fentanyl8%
    Part D<11 patients
    Gabapentinoids4.1%
    Gabapentin100%
    Part D≥27 patients

    + 6 more classes in this area

Where care is delivered (Part B)65.3% facility · 34.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 2026–2026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”